Subjects with a long promoter for the HMOX1 gene (associated with decreased HO-1 anticoagulant activity) present an increased risk of recurrent venous thromboembolism [116], whilst HO-1 has been demonstrated to exert a significant antiviral activity against a wide variety of viruses [117]. The gene discussed is HMOX1; the disease is venous thromboembolism.